Dashboard
Manage Tickers

DRIODarioHealth Corp.

Nasdaq mydario.com


$ 0.79 $ -0.02 (-2.28 %)    

Monday, 09-Sep-2024 15:23:34 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 455.25 $ 5.77 (1.29 %)
DIA $ 409.08 $ 4.58 (1.13 %)
SPY $ 546.60 $ 6.05 (1.12 %)
TLT $ 99.96 $ 0.43 (0.43 %)
GLD $ 231.58 $ 0.97 (0.42 %)
$ 0.816
$ 0.77
$ 0.78 x 182
$ 0.80 x 2,000
$ 0.75 - $ 0.80
$ 0.68 - $ 3.49
300,624
na
24.5M
$ 1.85
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-08-2024 06-30-2024 10-Q
2 05-15-2024 03-31-2024 10-Q
3 03-28-2024 12-31-2023 10-K
4 11-02-2023 09-30-2023 10-Q
5 08-10-2023 06-30-2023 10-Q
6 05-11-2023 03-31-2023 10-Q
7 03-09-2023 12-31-2022 10-K
8 11-14-2022 09-30-2022 10-Q
9 08-15-2022 06-30-2022 10-Q
10 05-11-2022 03-31-2022 10-Q
11 03-21-2022 12-31-2021 10-K
12 11-15-2021 09-30-2021 10-Q
13 08-16-2021 06-30-2021 10-Q
14 05-17-2021 03-31-2021 10-Q
15 03-09-2021 12-31-2020 10-K
16 11-12-2020 09-30-2020 10-Q
17 08-12-2020 06-30-2020 10-Q
18 05-12-2020 03-31-2020 10-Q
19 03-17-2020 12-31-2019 10-K
20 10-28-2019 09-30-2019 10-Q
21 08-13-2019 06-30-2019 10-Q
22 05-13-2019 03-31-2019 10-Q
23 03-25-2019 12-31-2018 10-K
24 11-13-2018 09-30-2018 10-Q
25 08-09-2018 06-30-2018 10-Q
26 05-15-2018 03-31-2018 10-Q
27 03-19-2018 12-31-2017 10-K
28 11-14-2017 09-30-2017 10-Q
29 08-14-2017 06-30-2017 10-Q
30 05-15-2017 03-31-2017 10-Q
31 03-22-2017 12-31-2016 10-K
32 11-10-2016 09-30-2016 10-Q
33 08-11-2016 06-30-2016 10-Q
34 05-11-2016 03-31-2016 10-Q
35 02-08-2016 12-31-2015 10-K
36 11-13-2015 09-30-2015 10-Q
37 08-12-2015 06-30-2015 10-Q
38 05-14-2015 03-31-2015 10-Q
39 03-24-2015 12-31-2014 10-K
40 11-14-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

dariohealth-q2-2024-gaap-eps-008-beats-056-estimate-sales-6255m-miss-7914m-estimate
DarioHealth Q2 2024 GAAP EPS $0.08 Beats $...
08/08/2024 10:10:06

dario-expands-glp-1-solution-client-base-with-new-employer-contract-financial-terms-not-disclosed
Dario Expands GLP-1 Solution Client Base W...
07/16/2024 12:32:09

Dario's leading behavior change solutions continue to win interest in the employer, payer and pharmaceutical markets

dariohealth-announces-two-new-studies-presented-at-ada-scientific-sessions-research-confirms-sustainable-behavior-change-over-12-months-with-dario-digital-platform-31-of-dario-members-with-type-2-diabetes-achieve-diabetes-remission-analysis-includes-members-tracking-glp-1-medication
DarioHealth Announces Two New Studies Pres...
06/25/2024 12:31:23

dariohealth-q1-net-loss-72m-compared-to-128m-yoy
DarioHealth Q1 Net Loss $(7.2)M Compared T...
05/15/2024 10:34:37

dariohealth-q1-sales-5758m-miss-6758m-estimate
DarioHealth Q1 Sales $5.758M Miss $6.758M ...
05/15/2024 10:32:58

DarioHealth (NASDAQ:DRIO) reported quarterly sales of $5.758 million which missed the analyst consensus estimate of $6.758 mill...

dario-publishes-new-peer-reviewed-study-that-deepens-the-body-of-evidence-that-managing-cardiometabolic-conditions-in-one-integrated-platform-improves-clinical-outcomes
Dario Publishes New Peer-Reviewed Study Th...
04/25/2024 12:47:01

Quasi-randomized study demonstrates the value of Dario's integrated approach to provide one solution for members to manage ...

dario-signs-two-employers-for-cardiometabolic-suite-with-integrated-glp-1-solution-beginning-in-q2-of-2024
Dario Signs Two Employers For Cardiometabo...
04/18/2024 12:34:17

Dario selected to provide integrated and proven solutions to improve employee cardiometabolic healthNEW YORK, April 18, 2024 /P...

dario-publishes-two-peer-reviewed-studies-demonstrating-impact-of-digital-behavioral-health
Dario Publishes Two Peer-Reviewed Studies ...
04/10/2024 12:34:41

Studies include a Randomized Controlled Trial demonstrating significant reduction in perceived stress for teens

two-national-employers-select-darios-integrated-chronic-condition-solution-to-improve-employee-health
Two National Employers Select Dario's Inte...
04/02/2024 12:40:18

DarioHealth Corp. (NASDAQ:DRIO) ("Dario" or the "Company"), a leader in the global digital health market, annou...

stifel-maintains-buy-on-dariohealth-maintains-4-price-target
Stifel Maintains Buy on DarioHealth, Maint...
04/01/2024 15:01:39

Stifel analyst David Grossman maintains DarioHealth (NASDAQ:DRIO) with a Buy and maintains $4 price target.

dariohealth-q4-eps-041-beats-054-estimate
DarioHealth Q4 EPS $(0.41) Beats $(0.54) E...
03/28/2024 10:43:02

DarioHealth (NASDAQ:DRIO) reported quarterly losses of $(0.41) per share which beat the analyst consensus estimate of $(0.54) b...

dariohealth-q4-sales-362m-beat-357m-estimate
DarioHealth Q4 Sales $3.62M Beat $3.57M Es...
03/28/2024 10:35:24

DarioHealth (NASDAQ:DRIO) reported quarterly sales of $3.62 million which beat the analyst consensus estimate of $3.57 million ...

earnings-scheduled-for-march-28-2024
Earnings Scheduled For March 28, 2024
03/28/2024 09:24:44

Companies Reporting Before The Bell • Universal Stainless (NASDAQ:USAP) is expected to report quarterly earnings at $0.32 per ...

earnings-outlook-for-dariohealth
Earnings Outlook For DarioHealth
03/27/2024 17:00:55

new-research-from-dario-demonstrates-ability-to-deliver-improved-health-outcomes-with-integrated-solution-for-members-managing-weight-and-blood-glucose-with-or-without-glp-1-medications
New Research From Dario Demonstrates Abili...
03/12/2024 12:49:55

Study presented at ATTD 2024 is the first of a planned series examining the impact of Dario's integrated cardiometabolic so...

concurrent-to-twill-acquisition-deal-dariohealth-priced-224m-equity-financing
Concurrent To Twill Acquisition Deal, Dari...
02/21/2024 11:05:58

Dario priced a $22.4 million private placement of convertible preferred stock, priced at the market under Nasdaq rules, with pa...

dariohealth-has-acquired-twill-to-create-comprehensive-digital-offerings-for-chronic-conditions-dario-paid-10m-in-cash-and-agreed-to-issue-approximately-10m-shares-in-the-form-of-pre-funded-warrants
Dariohealth Has Acquired Twill, To Create ...
02/21/2024 11:04:15

Expecting nearly doubling Dario's pro forma revenues in 2023 Acquisition is immediately accretive to revenue and gross mar...

12-health-care-stocks-moving-in-fridays-pre-market-session
12 Health Care Stocks Moving In Friday's P...
01/12/2024 13:05:59

darios-cardiometabolic-announces-contract-to-provide-cardiometabolic-solutions-to-regional-union-financial-terms-not-disclosed
Dario's Cardiometabolic Announces Contract...
01/11/2024 13:33:20

Dario's integrated solution to support improved whole health gains traction in public and labor market

national-employer-selects-dario-cardiometabolic-and-glp-1-solutions-to-improve-employee-health
National Employer Selects Dario Cardiometa...
12/05/2023 13:40:54

New client will use Dario's integrated approach to support long-term behavior change for employees living with diabetes, pr...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION